Learn About the Quiz
View Product Details
Available for Free on the App Store
Myriad Customer Service
Decrease costs while improving patient well-being
Learn More »
Accurate test results drive optimal treatments
If you are a payer or insurance provider, please contact us to receive more information.
EVP, Corporate Communications
VP, Investor Relations
800 4-MYRIAD (800 469-7423)
Myriad Genetics, Inc.
320 Wakara Way
Salt Lake City, UT 84108
At Myriad, our passion for patients drives everything we do – on the job and in the community.
Myriad is answering patients’ most pressing questions about disease.
Myriad has the deepest diagnostic pipeline across the disease spectrum.
At Myriad, we’re leveraging our unique expertise in sequencing and analysis to better understand human disease.
The Myriad myRisk Hereditary Cancer test is a 29-gene panel that identifies an elevated risk for eight hereditary cancers.
EndoPredict helps doctors guide ER+, HER2- early-stage breast cancer patients toward the appropriate treatment decision.
GeneSight meets a significant unmet clinical need and is the leading product for psychotropic drug selection.
Dec 07, 2018
Vectra is an advanced blood test that measures rheumatoid arthritis disease activity.
Prolaris aids healthcare professionals in predicting prostate cancer aggressiveness and disease progression.
Take a 30-second quiz to help you find out if you’re at risk of hereditary cancer.
Myriad Genetics First Quarter Fiscal 2019 Financial Results Conference Call
November 6, 2018
4:30 PM ET